BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9881704)

  • 1. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer.
    Tsutsumi M; Tsai YC; Gonzalgo ML; Nichols PW; Jones PA
    Oncogene; 1998 Dec; 17(23):3021-7. PubMed ID: 9881704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
    Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
    Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression.
    Swellam M; El-Aal AA; AbuGabel KM
    Clin Biochem; 2004 Dec; 37(12):1098-104. PubMed ID: 15589816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
    IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines.
    Gonzalgo ML; Hayashida T; Bender CM; Pao MM; Tsai YC; Gonzales FA; Nguyen HD; Nguyen TT; Jones PA
    Cancer Res; 1998 Mar; 58(6):1245-52. PubMed ID: 9515812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Loss of p16 gene in bladder cancer and genitourinary carcinoma cell lines].
    Guo D; Gu F; Zhou A
    Zhonghua Wai Ke Za Zhi; 1996 Nov; 34(11):643-4. PubMed ID: 9590746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
    Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
    Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer.
    Berggren de Verdier PJ; Kumar R; Adolfsson J; Larsson P; Norming U; Onelöv E; Wijkström H; Steineck G; Hemminki K
    Scand J Urol Nephrol; 2006; 40(5):363-9. PubMed ID: 17060081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
    Balázs M; Carroll P; Kerschmann R; Sauter G; Waldman FM
    Genes Chromosomes Cancer; 1997 Jun; 19(2):84-9. PubMed ID: 9171998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
    Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of p16INK4A gene alterations in hepatocellular carcinoma.
    Liew CT; Li HM; Lo KW; Leow CK; Chan JY; Hin LY; Lau WY; Lai PB; Lim BK; Huang J; Leung WT; Wu S; Lee JC
    Oncogene; 1999 Jan; 18(3):789-95. PubMed ID: 9989830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype.
    Chapman EJ; Harnden P; Chambers P; Johnston C; Knowles MA
    Clin Cancer Res; 2005 Aug; 11(16):5740-7. PubMed ID: 16115911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased p16 levels correlate with pRb alterations in human urothelial cells.
    Yeager T; Stadler W; Belair C; Puthenveettil J; Olopade O; Reznikoff C
    Cancer Res; 1995 Feb; 55(3):493-7. PubMed ID: 7834615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma.
    Bazan V; Zanna I; Migliavacca M; Sanz-Casla MT; Maestro ML; Corsale S; Macaluso M; Dardanoni G; Restivo S; Quintela PL; Bernaldez R; Salerno S; Morello V; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 Sep; 192(3):286-93. PubMed ID: 12124774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas.
    Wong DJ; Barrett MT; Stöger R; Emond MJ; Reid BJ
    Cancer Res; 1997 Jul; 57(13):2619-22. PubMed ID: 9205067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
    Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.
    Packenham JP; Taylor JA; Anna CH; White CM; Devereux TR
    Mol Carcinog; 1995 Nov; 14(3):147-51. PubMed ID: 7576106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
    Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM
    J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.